PineStone Asset Management’s Medpace MEDP Stock Holding History

PineStone Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$932K	Sell	1,760 -880	-33%	-$406K	0.01%	35
2026 Q1	$1.27M	Sell	2,640 -22,060	-89%	-$11.3M	0.01%	35
2025 Q4	$13.9M	Sell	24,700 -4,500	-15%	-$2.55M	0.09%	30
2025 Q3	$15M	Sell	29,200 -7,100	-20%	-$3.1M	0.09%	32
2025 Q2	$11.4M	Hold	36,300	–	–	0.07%	34
2025 Q1	$11.1M	Hold	36,300	–	–	0.08%	37
2024 Q4	$12.1M	Hold	36,300	–	–	0.11%	35
2024 Q3	$12.1M	Hold	36,300	–	–	0.12%	38
2024 Q2	$15M	Sell	36,300 -2,000	-5%	-$792K	0.16%	31
2024 Q1	$15.5M	Sell	38,300 -4,100	-10%	-$1.44M	0.25%	31
2023 Q4	$13M	Buy	42,400 +4,000	+10%	+$1.08M	0.14%	31
2023 Q3	$9.3M	Buy	+38,400	New	+$9.82M	0.13%	33

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

PineStone Asset Management's MEDP Position: Q2 2026 in Review

PineStone Asset Management reduced its Medpace (MEDP) stake by 33% in Q2 2026, selling an estimated $406K and leaving 1,760 shares worth $932K. The position accounts for 0.01% of the portfolio, ranked #35.

PineStone Asset Management first reported a position in MEDP in Q3 2023 and has held it in 12 quarters since. The position peaked at $15.5M in Q1 2024. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

PineStone Asset Management held 1,760 shares of Medpace worth $932K as of Q2 2026.
PineStone Asset Management sold 880 Medpace shares in Q2 2026, an estimated $406K.
Medpace made up 0.01% of PineStone Asset Management's portfolio in Q2 2026, its #35 holding.
PineStone Asset Management first reported a position in Medpace in Q3 2023 and has held it in 12 quarters since.
PineStone Asset Management's Medpace position peaked at $15.5M in Q1 2024.
694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on PineStone Asset Management's 13F filing for Q2 2026, filed 13 Jul 2026.